CAS RN: 955400-58-5
2-(Pyridazin-4-yl)thiazole-4-carboxylic acid
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260304
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 955400-58-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Beijing
Inquiry
955400-58-5 / 2-pyridazin-4-yl-1,3-thiazole-4-carboxylic acid
Standard CAS: 955400-58-5
Multi CAS: No
Basic Information
copy
CAS
955400-58-5 copy
Multi CAS
No copy
Molecular Formula
C8H5N3O2S copy
Molecular Weight
207.210000 copy
Exact Mass
207.010248 copy
InChI
InChI=1S/C8H5N3O2S/c12-8(13)6-4-14-7(11-6)5-1-2-9-10-3-5/h1-4H,(H,12,13) copy
InChIKey
TVEWUGABIVCMQS-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
11 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
H-bond donors
1 copy
Molar refractivity
50.1 copy
TPSA
75.97 copy
LogP / Solubility
WLOGP
1.3 copy
MLOGP
1.14 copy
XLogP3
0.4 copy
Consensus LogP
0.95 copy
Log S (ESOL)
-2.39 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.2 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.32 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.06 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy